Accendra Health Inc Cash Flow Conversion Efficiency
Accendra Health Inc cash flow conversion efficiency. Based on the latest financial reports, Accendra Health Inc (ACH) has a cash flow conversion efficiency ratio of -0.148x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($68.19 Million) by net assets ($-460.98 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Accendra Health Inc (1985–2025)
Cash flow conversion efficiency of Accendra Health Inc from 1985 to 2025. This chart illustrates how Accendra Health Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ACH stock price for real-time trading data and today's change.
Accendra Health Inc Cash Flow Conversion Ratio Explained
Accendra Health Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Accendra Health Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Accendra Health Inc ranked by their cash flow conversion efficiency. Also see market cap of Accendra Health Inc for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ABERA BIOSCIENCE AB
F:8WK
|
-0.317x |
|
First Hydrogen Corp
V:FHYD
|
0.122x |
|
Honkarakenne Oyj B
HE:HONBS
|
-0.200x |
|
Polwax SA
WAR:PWX
|
-0.416x |
|
Saga plc
LSE:SAGA
|
0.721x |
|
CHEMOMAB THERAP. ADR/20
F:2QV0
|
N/A |
|
Cheetah Holdings Bhd
KLSE:7209
|
0.136x |
|
HPMT Holdings Bhd
KLSE:5291
|
-0.045x |
Annual Cash Flow Conversion Efficiency for Accendra Health Inc (1985–2025)
The table below shows the annual cash flow conversion efficiency of Accendra Health Inc from 1985 to 2025. Review ACH FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-460.98 Million | $-101.79 Million | 0.221x | -22.72% |
| 2024-12-31 | $565.23 Million | $161.50 Million | 0.286x | -64.35% |
| 2023-12-31 | $924.17 Million | $740.71 Million | 0.801x | +133.19% |
| 2022-12-31 | $945.60 Million | $325.01 Million | 0.344x | +159.76% |
| 2021-12-31 | $938.50 Million | $124.18 Million | 0.132x | -72.23% |
| 2020-12-31 | $712.05 Million | $339.22 Million | 0.476x | +32.56% |
| 2019-12-31 | $462.15 Million | $166.09 Million | 0.359x | +61.18% |
| 2018-12-31 | $518.42 Million | $115.59 Million | 0.223x | +298.80% |
| 2017-12-31 | $1.02 Billion | $56.77 Million | 0.056x | -71.29% |
| 2016-12-31 | $960.04 Million | $186.93 Million | 0.195x | -28.31% |
| 2015-12-31 | $992.59 Million | $269.60 Million | 0.272x | +7255.57% |
| 2014-12-31 | $990.84 Million | $-3.76 Million | -0.004x | -102.77% |
| 2013-12-31 | $1.03 Billion | $140.55 Million | 0.137x | -38.90% |
| 2012-12-31 | $973.66 Million | $218.51 Million | 0.224x | +202.74% |
| 2011-12-31 | $919.22 Million | $68.14 Million | 0.074x | -73.83% |
| 2010-12-31 | $857.52 Million | $242.92 Million | 0.283x | +24.10% |
| 2009-12-31 | $769.18 Million | $175.58 Million | 0.228x | +152.34% |
| 2008-12-31 | $695.10 Million | $62.88 Million | 0.090x | -74.72% |
| 2007-12-31 | $614.36 Million | $219.84 Million | 0.358x | +366.24% |
| 2006-12-31 | $547.45 Million | $-73.58 Million | -0.134x | -150.83% |
| 2005-12-31 | $512.00 Million | $135.37 Million | 0.264x | +107.48% |
| 2004-12-31 | $460.26 Million | $58.65 Million | 0.127x | -44.90% |
| 2003-12-31 | $410.36 Million | $94.90 Million | 0.231x | +540.16% |
| 2002-12-31 | $271.44 Million | $-14.26 Million | -0.053x | -1279.06% |
| 2001-12-31 | $368.24 Million | $1.64 Million | 0.004x | -96.44% |
| 2000-12-31 | $344.77 Million | $43.16 Million | 0.125x | -57.36% |
| 1999-12-31 | $314.40 Million | $92.30 Million | 0.294x | +164.76% |
| 1998-12-31 | $293.10 Million | $32.50 Million | 0.111x | +259.40% |
| 1997-12-31 | $259.30 Million | $8.00 Million | 0.031x | -96.02% |
| 1996-12-31 | $242.40 Million | $188.10 Million | 0.776x | +1701.67% |
| 1995-12-31 | $235.30 Million | $-11.40 Million | -0.048x | +91.94% |
| 1994-12-31 | $256.10 Million | $-153.90 Million | -0.601x | -722.68% |
| 1993-12-31 | $136.90 Million | $-10.00 Million | -0.073x | -330.39% |
| 1992-12-31 | $116.70 Million | $3.70 Million | 0.032x | -80.88% |
| 1991-12-31 | $97.10 Million | $16.10 Million | 0.166x | -35.05% |
| 1990-12-31 | $85.00 Million | $21.70 Million | 0.255x | -89.71% |
| 1985-12-31 | $35.90 Million | $89.10 Million | 2.482x | -- |
About Accendra Health Inc
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level pos… Read more